A cell-free browning strategy: Exosomal miR-21a-5p from ADSCs targets PDCD4 to reshape adipose metabolism.

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

• Level A · Stronger Clinical Evidence
• Level B · Emerging clinical evidence with positive signals
• Level C · Early human research exploring benefits
• Level D · Scientific groundwork from lab and animal studies
• Emerging · Emerging topic under active research

Abstract (original English)

Adipose-derived stem cell exosomes (ADSC-EXOs) serve as cell-free therapy, transporting signaling molecules that modulate adipose plasticity. However, the precise molecular mechanisms involved remain unclear. We used a high-fat diet-induced mouse obesity model and an MDI-induced 3T3-L1 cell differentiation model. We found that ADSC-EXOs improved systemic glucose and lipid metabolism, decreased PDCD4 and white adipocyte marker expression, and increased brown adipocyte marker expression along with the activation of the LXR-α/Akt pathway in inguinal adipose tissue. miR-21a-5p mimic or siPDCD4 transfection in 3T3-L1 cells recapitulated these effects, reducing lipid accumulation and promoting adipocyte browning, whereas PDCD4 overexpression produced the opposite effects. Mechanistically, miR-21a-5p directly targeted the 3' UTR of PDCD4. These findings indicate that ADSC-EXOs facilitate white fat browning through the miR-21a-5p/PDCD4 axis and thus activate the LXR-α/Akt signaling pathway, offering a potential therapeutic strategy for obesity-related metabolic dysfunction.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.